Search Results

Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

• Authors : Dietrich U; Ruppach H; Gehring S

Subjects: Mutation*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Seropositivity/HIV Seropositivity/HIV Seropositivity/*virology

• Source: AIDS (London, England) [AIDS] 1997 Oct; Vol. 11 (12), pp. 1532-3.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Print ISSN:

Record details

Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

• Authors : Stürmer M; J.W. Goethe University Hospital, Institute for Medical Virology, Frankfurt, Germany. ; Dauer B

Subjects: Mutation*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; DNA, Viral/DNA, Viral/DNA, Viral/*blood

• Source: Antiviral therapy [Antivir Ther] 2007; Vol. 12 (1), pp. 25-30.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Print ISSN: 1359-6535 (Print)

Record details

[AIDS: therapeutic changes in the second decade. Triple combination--HIV vaccination].

• Authors : Jäger H; Kuratorium für Immunschwäche, München.

Subjects: AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*administration & dosage ; Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*therapy ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage

• Source: Fortschritte der Medizin [Fortschr Med] 1993 May 30; Vol. 111 (15), pp. 20-1.Publisher: Urban Und Vogel Country of Publication: Germany NLM ID: 2984763R Publication Model: Print Cited Medium: Print

Record details

Zidovudine Open House Drug Discount Contracts.

• Source: Mena Report. 2016.

Record details

Reports Summarize Pathology Study Results from University Medical Center (Zidovudine induces visceral mitochondrial toxicity and intra-abdominal fat gain in a rodent model of lipodystrophy).

• Source: Drug Week. 2015, pages. 256

Record details

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.

• Authors : Cong, Yu; Dyall, Julie; Hart, Brit J.

• Source: PLoS ONE. November 30, 2016, Vol. 11 Issue 11, e0166318.

Record details

Zidovudine Resistance Mutations Increase Abacavir Resistance.

• Source: AIDS Weekly. 2002, pages. 9

Record details

nevirapine, lamivudine + zidovudine Boehringer Ingelheim, GlaxoSmithKline, Boehringer Ingelheim, GlaxoSmithKline sign letter of intent.

• Source: R & D Focus Drug News. 2005.

Record details

lamivudine + zidovudine + abacavir GlaxoSmithKline marketed, Germany.

• Source: R & D Focus Drug News. 2001.

Record details

lamivudine + zidovudine + abacavir GlaxoSmithKline marketed, Austria, Switzerland, Germany.

• Source: R & D Focus Drug News. 2001.

Record details